Onxeo (Two Non-Core Products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Onxeo (Two Non-Core Products) General Information

Description

A portfolio of non core pharmaceutical products in Paris, France. It comprises the products in oral pathology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 49 boulevard du Général Martial Valin
  • 75015 Paris
  • France
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 49 boulevard du Général Martial Valin
  • 75015 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Onxeo (Two Non-Core Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Onxeo (Two Non-Core Products)‘s full profile, request access.

Request a free trial

Onxeo (Two Non-Core Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Onxeo (Two Non-Core Products)‘s full profile, request access.

Request a free trial

Onxeo (Two Non-Core Products) FAQs

  • Where is Onxeo (Two Non-Core Products) headquartered?

    Onxeo (Two Non-Core Products) is headquartered in Paris, France.

  • What industry is Onxeo (Two Non-Core Products) in?

    Onxeo (Two Non-Core Products)’s primary industry is Buildings and Property.

  • Is Onxeo (Two Non-Core Products) a private or public company?

    Onxeo (Two Non-Core Products) is a Private company.

  • What is Onxeo (Two Non-Core Products)’s current revenue?

    The current revenue for Onxeo (Two Non-Core Products) is .

  • Who are Onxeo (Two Non-Core Products)’s investors?

    Valerio Therapeutics has invested in Onxeo (Two Non-Core Products).

  • When was Onxeo (Two Non-Core Products) acquired?

    Onxeo (Two Non-Core Products) was acquired on 31-Jul-2017.

  • Who acquired Onxeo (Two Non-Core Products)?

    Onxeo (Two Non-Core Products) was acquired by Vectans Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process